The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: Phenotypic, genetic and reference genome characterization

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 11, 2016, Pages 3096-3108

  Unemo, Magnus ^a   Golparian, Daniel ^a   Sánchez Busó, Leonor ^b   Grad, Yonatan ^c,d   Jacobsson, Susanne ^a   Ohnishi, Makoto ^e   Lahra, Monica M ^f   Limnios, Athena ^f   Sikora, Aleksandra E ^g   Wi, Teodora ^h   Harris, Simon R ^b  

^a ÖREBRO UNIVERSITY   (Sweden)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f PRINCE OF WALES HOSPITAL   (Australia)

^g OREGON STATE UNIVERSITY   (United States)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERTAPENEM; ERYTHROMYCIN; FOSFOMYCIN; GEMIFLOXACIN; GENTAMICIN; KANAMYCIN; MOXIFLOXACIN; PENICILLIN G; PROLINE IMINOPEPTIDASE; PROLYLIMINOPEPTIDASE; RIFAMPICIN; SOLITHROMYCIN; SPECTINOMYCIN; SULFAMETHOXAZOLE; TEMOCILLIN; TETRACYCLINE; THIAMPHENICOL; UNCLASSIFIED DRUG; ZOLIFLODACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL STRAIN; CONTROLLED STUDY; GENE SEQUENCE; LABORATORY TEST; NEISSERIA GONORRHOEAE; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; PLASMID; QUALITY CONTROL; SEROTYPE; WORLD HEALTH ORGANIZATION; ANALYSIS; BACTERIAL GENE; DRUG EFFECTS; GENETICS; GENOTYPE; GONORRHEA; HEALTH CARE QUALITY; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; PHYSIOLOGY; STANDARD; STANDARDS;

ANTI-BACTERIAL AGENTS; GENES, BACTERIAL; GENOME, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; NEISSERIA GONORRHOEAE; PLASMIDS; QUALITY ASSURANCE, HEALTH CARE; REFERENCE STANDARDS; SEROGROUP;

EID: 84994481826     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw288     Document Type: Article

References (82)

1. Newman L, Rowley J, Vander Hoorn S et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 2015; 10: e0143304.
2. WHO. Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. 2012. http://whqlibdoc. who.int/publications/2012/9789241503501_eng.pdf?ua=1.
3. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7: 1401-22.
4. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014; 27: 587-613.
5. Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
6. Cámara J, Serra J, Ayats J et al. Molecular characterization of two highlevel ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012; 67: 1858-60.
7. Unemo M, Golparian D, Nicholas R et al. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273-80.
8. Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med 2014; 371: 1850-1.
9. Chen SC, Yin YP, Dai XQ et al. Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother 2014; 69: 2959-65.
10. Unemo M, Golparian D, Stary A et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 2011; 16: pii=19998.
11. Golparian D, Ohlsson A, Janson H et al. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Euro Surveill 2014; 19: pii=20862.
12. Chen YM, Stevens K, Tideman R et al. Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother 2013; 68: 1445-7.
13. Read PJ, Limnios EA, McNulty A et al. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia. Sex Health 2013; 10: 460-2.
14. Unemo M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015; 15: 364.
15. CDC. Cephalosporin-Resistant Neisseria gonorrhoeae Public Health Response Plan. 2012; 1-43. http://www.cdc.gov/std/gonorrhea/default.htm.
16. ECDC. Response Plan to Control and Manage the Threat of Multidrug-Resistant Gonorrhoea in Europe. 2012; 1-23. www.ecdc.europa.eu/en/publications/Publications/1206-ECDC-MDR-gonorrhoea-response-plan.pdf.
17. Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 2012; 88: 317-8.
18. Cole MJ, Spiteri G, Jacobsson S et al. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. BMC Infect Dis 2015; 15: 321.
19. Chisholm SA, Unemo M, Quaye N et al. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013; 18: pii=20358.
20. Kirkcaldy RD, Hook EW 3rd, Soge OO et al. Trends in Neisseria gonorrhoeae susceptibility to cephalosporins in the United States, 2006-2014. JAMA 2015; 314: 1869-71.
21. Ison CA, Town K, Obi C et al. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. Lancet Infect Dis 2013; 13: 762-8.
22. Reyn A, Bentzon MW, Thayer JD et al. Results of comparative experiments using different methods for determining the sensitivity of Neisseria gonorrhoeae. Bull WHO 1965; 32: 477-502.
23. Unemo M, Fasth O, Fredlund H et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
24. Ison C, Golparian D, Saunders P et al. Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea-false negative gonococcal porA mutants are spreading internationally. Sex Transm Infect 2013; 89: 197-201.
25. Golparian D, Johansson E, Unemo M. Clinical Neisseria gonorrhoeae isolate with a N. meningitidis porA gene and no prolyliminopeptidase activity, Sweden, 2011-danger of false-negative genetic and culture diagnostic results. Euro Surveill 2012; 17: pii=20102.
26. Unemo M, Golparian D, Hellmark B. First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? Antimicrob Agents Chemother 2013; 58: 624-5.
27. Lo JYC, Ho KM, Leung AOC et al. Ceftibuten resistance and treatment failure in gonococcal infection. Antimicrob Agent Chemother 2008; 52: 3564-7.
28. Unemo M, Olcén P, Berglund T et al. Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J Clin Microbiol 2002; 40: 3741-9.
29. Unemo M, Sjöstrand A, Akhras M et al. Molecular characterisation of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin resistant strain. APMIS 2007; 115: 231-41.
30. Jolley KA. Multi-locus sequence typing. In: Pollard AJ, Maiden MC, eds. Meningococcal Disease: Methods and Protocols. Totowa, NJ: Humana Press, 2001; 173-86.
31. Hunt M, Silva ND, Otto TD et al. Circlator: automated circularization of genome assemblies using long sequencing reads. Genome Biol 2015; 16: 294.
32. Chin CS, Alexander DH, Marks P et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 2013; 10: 563-9.
33. Makendi C, Page AJ, Wren BW et al. A phylogenetic and phenotypic analysis of Salmonella enterica serovar weltevreden, an emerging agent of diarrheal disease in tropical regions. PLoS Negl Trop Dis 2016; 10: e0004446.
34. Carver TJ, Rutherford KM, Berriman M et al. ACT: the Artemis Comparison Tool. Bioinformatics 2005; 21: 3422-3.
35. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26: 589-95.
36. Li H. Minimap and miniasm: fast mapping and de novo assembly for noisy long sequences. Bioinformatics 2016; doi:10.1093/bioinformatics/btw152.
37. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30: 2068-9.
38. Rutherford K, Parkhill J, Crook J et al. Artemis: sequence visualization and annotation. Bioinformatics 2000; 16: 944-5.
39. Jones P, Binns D, Chang HY et al. InterProScan 5: genome-scale protein function classification. Bioinformatics 2014; 30: 1236-40.
40. Camacho C, Coulouris G, Avagyan V et al. BLAST+: architecture and applications. BMC Bioinformatics 2009; 10: 421.
41. Alikhan NF, Petty NK, Ben Zakour NL et al. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 2011; 12: 402.
42. Page AJ, Cummins CA, Hunt M et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31: 3691-3.
43. Tamura K, Stecher G, Peterson D et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013; 30: 2725-9.
44. Ohneck EA, Zalucki YM, Johnson PJ et al. A novel mechanism of highlevel, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio 2011; 2: e00187-11.
45. Palmer HM, Leeming JP, Turner A. A multiplex polymerase chain reaction to differentiate b-lactamase plasmids of Neisseria gonorrhoeae. J Antimicrob Chemother 2000; 45: 777-82.
46. Muhammad I, Golparian D, Dillon JA et al. Characterisation of blaTEM genes and types of b-lactamase plasmids in Neisseria gonorrhoeae-the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis 2014; 14: 454.
47. Trees DL, Sandul AL, Peto-Mesola V et al. Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States. Int J Antimicrob Agents 1999; 12: 325-32.
48. Galimand M, Gerbaud G, Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Chemother 2000; 44: 1365-6.
49. Ng L-K, Martin I, Liu G et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 3020-5.
50. Luna VA, Cousin S Jr, Whittington WL et al. Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother 2000; 44: 2503-6.
51. Cousin SL Jr, Whittington WL, Roberts MC. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. J Antimicrob Chemother 2003; 51: 131-3.
52. Nolte O, Müller M, Reitz S et al. Description of new mutations in the rpoB gene in rifampicin-resistant Neisseria meningitidis selected in vitro in a stepwise manner. J Med Microbiol 2003; 52: 1077-81.
53. Turner A, Gough KR, Leeming JP. Molecular epidemiology of tetM genes in Neisseria gonorrhoeae. Sex Transm Infect 1999; 75: 60-6.
54. Hu M, Nandi S, Davies C et al. High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob Agents Chemother 2005; 49: 4327-34.
55. Fiebelkorn KR, Crawford SA, Jorgensen JH. Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents. Antimicrob Agents Chemother 2005; 49: 536-40.
56. Rouquette-Loughlin CE, Balthazar JT, Shafer WM. Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J Antimicrob Chemother 2005; 56: 856-80.
57. Rouquette-Loughlin CE, Dunham SA, Kuhn M et al. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J Bacteriol 2003; 185: 1101-6.
58. Hamilton HL, Domínguez NM, Schwartz KJ et al. Neisseria gonorrhoeae secretes chromosomal DNA via a novel type IV secretion system. Mol Microbiol 2005; 55: 1704-21.
59. WHO GASP Document 'Rationale and Applications for the Current (2008) WHO Panel of Neisseria gonorrhoeae for Antimicrobial Resistance Surveillance for Public Health Purposes, and Instructions for Their Use'. Technical document D007-0408-1#1. Sydney: WHO Collaborating Centre for STD, 2008.
60. Low N, Unemo M. Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? Curr Opin Infect Dis 2016; 29: 45-51.
61. Goire N, Lahra MM, Chen M et al. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat Rev Microbiol 2014; 12: 223-9.
62. Whiley DM, Lahra MM, Unemo M. Prospects of untreatable gonorrhea and ways forward. Future Microbiol 2015; 10: 313-6.
63. Unemo M, Dillon JA. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev 2011; 24: 447-58.
64. Roberts MC, Chung WO, Roe D et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 1999; 43: 1367-72.
65. Korch C, Hagblom P, Ohman H et al. Cryptic plasmid of Neisseria gonorrhoeae: complete nucleotide sequence and genetic organization. J Bacteriol 1985; 163: 430-8.
66. Ho BS, Feng WG, Wong BK et al. Polymerase chain reaction for the detection of Neisseria gonorrhoeae in clinical samples. J Clin Pathol 1992; 45: 439-42.
67. Lum G, Freeman K, Nguyen NL et al. A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR. Sex Transm Infect 2005; 81: 400-2.
68. Unemo M, Palmer HM, Blackmore T et al. Global transmission of prolyliminopeptidase-negative Neisseria gonorrhoeae strains: implications for changes in diagnostic strategies. Sex Transm Infect 2007; 83: 47-51.
69. Tomberg J, Unemo M, Davies C et al. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 2010; 49: 8062-70.
70. Tomberg J, Unemo M, Ohnishi M et al. Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041. Antimicrob Agents Chemother 2013; 57: 3029-36.
71. Unemo M, Nicholas RA, Jerse AE et al. Molecular mechanisms of antibiotic resistance expressed by the pathogenic Neisseria. In: Davies JK, Kahler CM, eds. Pathogenic Neisseria: Genomics, Molecular Biology and Disease Intervention. London: Caister Academic Press, 2014; 161-92.
72. Whiley DM, Goire N, Lambert SB et al. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother 2010; 65: 1615-8.
73. Folster JP, Johnson PJ, Jackson L et al. MtrR modulates rpoH expression and levels of antimicrobial resistance in Neisseria gonorrhoeae. J Bacteriol 2009; 191: 287-97.
74. Veal WL, Nicholas RA, Shafer WM. Overexpression of the MtrCMtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol 2002; 184: 5619-24.
75. Zarantonelli L, Borthagaray G, Lee EH et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother 1999; 43: 2468-72.
76. Hagman KE, Pan W, Spratt BG et al. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 1995; 141: 611-22.
77. Olesky M, Hobbs M, Nicholas RA. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 2811-20.
78. Olesky M, Zhao S, Rosenberg RL et al. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. J Bacteriol 2006; 188: 2300-8.
79. Ropp PA, Hu M, Olesky M et al. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for highlevel chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 769-77.
80. Lindbäck E, Rahman M, Jalal S et al. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 2002; 110: 651-7.
81. Pachulec E, van der Does C. Conjugative plasmids of Neisseria gonorrhoeae. PLoS One 2010; 5: e9962.
82. Pagotto F, Aman AT, Ng LK et al. Sequence analysis of the family of penicillinase-producing plasmids of Neisseria gonorrhoeae. Plasmid 2000; 43: 23-34.